A national pharmacare plan for Canadians holds as many unanswered questions now as it did before the federal election wi

Organizations that are committed to delivering and measuring employee wellness programs are seeing their investment pay

McKesson Canada President Paula Keays is appealing to the pharmaceutical and medical industry to improve accessibility t

Rising drug costs are plaguing public and private health insurance plans alike. In response to this trend, British Colum

SSQ Insurance announced Oct. 1 that it will now offer coverage for pharmacogenetic tests to members of its group insuran

Employer-sponsored medical benefits costs in Canada are on the rise, expected to increase six per cent in 2020, outpacin

A new report by the Patented Medicine Prices Review Board (PMPRB) reveals that prescription drug expenditures by Canadia